AAAAAA

   
Results: 1-15 |
Results: 15
SELECTION OF LOCAL THERAPY AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTSWITH STAGE IIIA,B BREAST-CANCER
Authors: DANFORTH DN ZUJEWSKI J OSHAUGHNESSY J RISEBERG D STEINBERG SM MCATEE N NOONE M CHOW C CHAUDHRY U LIPPMAN M JACOBSON J OKUNIEFF P COWAN KH
Citation: Dn. Danforth et al., SELECTION OF LOCAL THERAPY AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTSWITH STAGE IIIA,B BREAST-CANCER, Annals of surgical oncology, 5(2), 1998, pp. 150-158
POSTCHEMOTHERAPY AND CYTOKINE PRETREATED MARROW STROMAL CELL-LAYERS SUPPRESS HEMATOPOIESIS FROM NORMAL DONOR CD34(+) CELLS
Authors: SCHWARTZ GN WARREN MK ROTHWELL SW ZUJEWSKI J HALVERSON DC COWAN KH TOLCHER A OSHAUGHNESSY J GRESS RE
Citation: Gn. Schwartz et al., POSTCHEMOTHERAPY AND CYTOKINE PRETREATED MARROW STROMAL CELL-LAYERS SUPPRESS HEMATOPOIESIS FROM NORMAL DONOR CD34(+) CELLS, Bone marrow transplantation, 22(5), 1998, pp. 457-468
THE UNIFORM APPROACH TO BREAST FINE-NEEDLE ASPIRATION BIOPSY
Authors: ABATI A ABELE J BACUS SS BEDROSSIAN C BEERLINE D BIBBO M CADY B COVELL J DAVEY D DAWSON A FORNAGE B FOSTER R FRABLE W GOLDFISCHER M GROHS H HENRY M HIJAZI Y HINDLE W HOWELL L KAMINSKY D KATZ R KLINE T KOSS L LANNIN DR LAYFIELD L LEIMAN G LEWIS M LINDHOLM K LJUNG BM MASOOD S MIYAZAKI J NEWSTEAD G OSHAUGHNESSY J PAGE D POWERS C ROLLINS S ROSENTHAL D SANCHEZ MA SCHMIDT W SIDAWY M SILVERMAN J SNEIGE N STAHL RE STANLEY M THOMAS P VAZQUEZ M WAISMAN J WOLMAN S WORSHAM GF WUNDERLICH C YAWN B
Citation: A. Abati et al., THE UNIFORM APPROACH TO BREAST FINE-NEEDLE ASPIRATION BIOPSY, Diagnostic cytopathology, 16(4), 1997, pp. 295-311
INHIBITORY EFFECTS OF POSTCHEMOTHERAPY AND GM-CSF PRETREATED MARROW STROMAL CELL-LAYERS ON HEMATOPOIESIS FROM NORMAL DONOR CD34+ CELLS
Authors: SCHWARTZ GN ROTHWELL SW ZUJEWSKI J HALVERSON DC OSHAUGHNESSY J COWAN KH GRESS RE
Citation: Gn. Schwartz et al., INHIBITORY EFFECTS OF POSTCHEMOTHERAPY AND GM-CSF PRETREATED MARROW STROMAL CELL-LAYERS ON HEMATOPOIESIS FROM NORMAL DONOR CD34+ CELLS, Blood, 90(10), 1997, pp. 3509-3509
PHASE I II STUDY OF 72-HOUR INFUSIONAL PACLITAXEL AND DOXORUBICIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH METASTATIC BREAST-CANCER/
Authors: FISHERMAN JS COWAN KH NOONE M DENICOFF A BERG S POPLACK D BALIS F VENZON D MCCABE M GOLDSPIEL B CHOW C OGNIBENE FP OSHAUGHNESSY J
Citation: Js. Fisherman et al., PHASE I II STUDY OF 72-HOUR INFUSIONAL PACLITAXEL AND DOXORUBICIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH METASTATIC BREAST-CANCER/, Journal of clinical oncology, 14(3), 1996, pp. 774-782
EARLY SUPPRESSIVE EFFECTS OF CHEMOTHERAPY AND CYTOKINE TREATMENT ON COMMITTED VERSUS PRIMITIVE HEMATOPOIETIC PROGENITORS IN PATIENT BONE-MARROW
Authors: SCHWARTZ GN HAKIM F ZUJEWSKI J SZABO JM CEPADA R RISEBERG D WARREN MK MACKALL CL SETZER A NOONE M COWAN KH OSHAUGHNESSY J GRESS RE
Citation: Gn. Schwartz et al., EARLY SUPPRESSIVE EFFECTS OF CHEMOTHERAPY AND CYTOKINE TREATMENT ON COMMITTED VERSUS PRIMITIVE HEMATOPOIETIC PROGENITORS IN PATIENT BONE-MARROW, British Journal of Haematology, 92(3), 1996, pp. 537-547
THE UNIFORM APPROACH TO BREAST FINE-NEEDLE ASPIRATION BIOPSY - A SYNOPSIS
Authors: ABATI A ABELE J BACUS SS BEDROSSIAN C BEERLINE D BIBBO M CADY B COVELL J DAVEY D DAWSON A FORNAGE B FOSTER R FRABLE W GOLDFISCHER M GROHS H HENRY M HIJAZI Y HINDLE W HOWELL L KAMINSKY D KATZ R KLINE T KOSS LG LANNIN DR LAYFIELD L LEIMAN G LEWIS M LINDHOLM K LJUNG BM MASOOD S MIYAZAKI J NEWSTEAD G OSHAUGHNESSY J PAGE D POWERS C ROLLINS S ROSENTHAL D SANCHEZ MA SCHMIDT W SIDAWY M SILVERMAN J SNEIGE N STAHL RE STANLEY M THOMAS P VAZQUEZ M WAISMAN J WOLMAN S WUNDERLICH C YAWN B
Citation: A. Abati et al., THE UNIFORM APPROACH TO BREAST FINE-NEEDLE ASPIRATION BIOPSY - A SYNOPSIS, Acta cytologica, 40(6), 1996, pp. 1120-1126
PHASE-I STUDY OF INTRAVENOUS LU-177-LABELED CC49 MURINE MONOCLONAL-ANTIBODY IN PATIENTS WITH ADVANCED ADENOCARCINOMA
Authors: MULLIGAN T CARRASQUILLO JA CHUNG Y MILENIC DE SCHLOM J FEUERSTEIN I PAIK C PERENTESIS P REYNOLDS J CURT G GOECKELER W FORDYCE W CHENG R RISEBERG D COWAN K OSHAUGHNESSY J
Citation: T. Mulligan et al., PHASE-I STUDY OF INTRAVENOUS LU-177-LABELED CC49 MURINE MONOCLONAL-ANTIBODY IN PATIENTS WITH ADVANCED ADENOCARCINOMA, Clinical cancer research, 1(12), 1995, pp. 1447-1454
POSITIVE SELECTION OF CD34(-CELLS USING AN IMMUNOAFFINITY COLUMN RESULTS IN T CELL-DEPLETION EQUIVALENT TO ELUTRIATION() HEMATOPOIETIC)
Authors: COTTLERFOX M CIPOLONE K YU M BERENSON R OSHAUGHNESSY J DUNBAR C
Citation: M. Cottlerfox et al., POSITIVE SELECTION OF CD34(-CELLS USING AN IMMUNOAFFINITY COLUMN RESULTS IN T CELL-DEPLETION EQUIVALENT TO ELUTRIATION() HEMATOPOIETIC), Experimental hematology, 23(4), 1995, pp. 320-322
MOLECULAR MECHANISMS OF CANCER-ASSOCIATED IMMUNOSUPPRESSION - PARADIGM OF T-CELL REGULATION
Authors: STEFANOVA I OSHAUGHNESSY J ZUJEWSKI J COWAN K REED E BOLEN JB WITTES RE HORAK ID
Citation: I. Stefanova et al., MOLECULAR MECHANISMS OF CANCER-ASSOCIATED IMMUNOSUPPRESSION - PARADIGM OF T-CELL REGULATION, Blood, 86(10), 1995, pp. 2873-2873
EARLY SUPPRESSIVE EFFECTS OF CHEMOTHERAPY ON BONE-MARROW MEGAKARYOCYTE PRECURSORS
Authors: SCHWARTZ GN SZABO JM ROSE WJ HALVERSON D HAKIM FT CEPEDA R ZUJEWSKI J OSHAUGHNESSY J COWAN KH GRESS RE WARREN MK
Citation: Gn. Schwartz et al., EARLY SUPPRESSIVE EFFECTS OF CHEMOTHERAPY ON BONE-MARROW MEGAKARYOCYTE PRECURSORS, Blood, 86(10), 1995, pp. 3619-3619
PACLITAXEL IN DOXORUBICIN-REFRACTORY OR MITOXANTRONE-REFRACTORY BREAST-CANCER - A PHASE I II TRIAL OF 96-HOUR INFUSION/
Authors: WILSON WH BERG SL BRYANT G WITTES RE BATES S FOJO A STEINBERG SM GOLDSPIEL BR HERDT J OSHAUGHNESSY J BALIS FM CHABNER BA
Citation: Wh. Wilson et al., PACLITAXEL IN DOXORUBICIN-REFRACTORY OR MITOXANTRONE-REFRACTORY BREAST-CANCER - A PHASE I II TRIAL OF 96-HOUR INFUSION/, Journal of clinical oncology, 12(8), 1994, pp. 1621-1629
PHARMACOKINETICS AND BIODISTRIBUTION OF INTRAVENOUS LU-177 CC49 MURINE MONOCLONAL-ANTIBODY (MAB) IN PATIENTS WITH METASTATIC ADENOCARCINOMA
Authors: CARRASQUILLO J MULLIGAN T CHUNG Y MILENIC D LORA M SCHLOM J GOECKELER W FORDYCE W CHENG R FEUERESTEIN I PERENTESIS P PALK CH CURT G COWAN K OSHAUGHNESSY J
Citation: J. Carrasquillo et al., PHARMACOKINETICS AND BIODISTRIBUTION OF INTRAVENOUS LU-177 CC49 MURINE MONOCLONAL-ANTIBODY (MAB) IN PATIENTS WITH METASTATIC ADENOCARCINOMA, The Journal of nuclear medicine, 35(5), 1994, pp. 160000100-160000101
ACUTE ARTERIAL THROMBOSIS IN A PATIENT WITH BREAST-CANCER AFTER CHEMOTHERAPY WITH 5-FLUOROURACIL, DOXORUBICIN, LEUCOVORIN, CYCLOPHOSPHAMIDE, AND INTERLEUKIN-3
Authors: THEODOSSIOU C KROOG G ETTINGHAUSEN S TOLCHER A COWAN K OSHAUGHNESSY J
Citation: C. Theodossiou et al., ACUTE ARTERIAL THROMBOSIS IN A PATIENT WITH BREAST-CANCER AFTER CHEMOTHERAPY WITH 5-FLUOROURACIL, DOXORUBICIN, LEUCOVORIN, CYCLOPHOSPHAMIDE, AND INTERLEUKIN-3, Cancer, 74(10), 1994, pp. 2808-2810
EFFECT OF STROMAL CELL-LAYERS FROM BONE-MARROW OF PATIENTS PRE-CHEMOTHERAPY AND POSTCHEMOTHERAPY ON GROWTH OF NORMAL CD34+ CELLS
Authors: SCHWARTZ GN WARREN MK SZABO JM MACKALL C HAKIM F RILEY J RISEBERG D SETZER A NOONE M COWAN K OSHAUGHNESSY J
Citation: Gn. Schwartz et al., EFFECT OF STROMAL CELL-LAYERS FROM BONE-MARROW OF PATIENTS PRE-CHEMOTHERAPY AND POSTCHEMOTHERAPY ON GROWTH OF NORMAL CD34+ CELLS, Blood, 84(10), 1994, pp. 10000343-10000343
Risultati: 1-15 |